CV Lattes
Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Biotecnologia from Universidade Federal da Bahia - Campus Anísio Teixeira (2013), master's at Genetics from Universidade de São Paulo (2016) and doctorate at Doutorado em Ciências from Universidade de São Paulo (2021). Has experience in Biotechnology (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Cervical cancer is the third leading cause of cancer death in women and is associated with persistent infection Human Papilloma Virus (HPV) by more than 99% of cases. Given the epidemiological importance of tumors induced by HPV and the paramount importance of developing active immunotherapies against these injuries during the past 12 years, we have developed a vaccine DNA-based therapeut…
The Laboratory for Vaccine Development (LDV) of USP created a therapeutic vaccine strategy for cervical cancer that employs a vector encoding the E7 protein of HPV-16 fused to glycoprotein D (gD) of herpes simplex virus type 1 (HSV -1). The pgDE7h DNA vaccine showed preventive and therapeutic properties in mice when they are challenged with TC-1 cells which express E6 and E7 oncoproteins …
Cervical cancer is the third leading cause of cancer death in women and is associated with persistent infection with Human Papilloma Virus (HPV) in more than 99% of the cases. Given the epidemiological relevance of tumors induced by HPV, development of effective therapeutic vaccines is a high priority. Therefore, we have developed a DNA-based therapeutic vaccine encoding the HPV-16 E7 pro…
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |